Growth Metrics

Insulet (PODD) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -2.47%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 37.81%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.82%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 32.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 61.06%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.57%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 14.40%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 66.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 66.23%
Dec 31, 2025 84.56%
Sep 30, 2025 186.61%
Jun 30, 2025 40.72%
Mar 31, 2025 18.05%
Dec 31, 2024 49.41%
Sep 30, 2024 76.02%
Jun 30, 2024 56.04%
Mar 31, 2024 467.74%
Dec 31, 2023 98.59%
Sep 30, 2023 58.84%
Jun 30, 2023 17.88%
Mar 31, 2023 125.47%
Dec 31, 2022 48.57%
Sep 30, 2022 -92.94%
Jun 30, 2022 -175.89%
Mar 31, 2022 84.04%
Dec 31, 2021 45.42%
Sep 30, 2021 101.68%
Jun 30, 2021 -181.07%
Mar 31, 2021 26.99%
Dec 31, 2020 -38.61%
Sep 30, 2020 102.98%
Jun 30, 2020 62.23%
Mar 31, 2020 35.92%
Dec 31, 2019 40.26%
Sep 30, 2019 33.38%
Jun 30, 2019 34.69%
Mar 31, 2019 34.67%
Dec 31, 2018 39.05%
Sep 30, 2018 28.12%
Jun 30, 2018 57.99%
Mar 31, 2018 15.72%
Dec 31, 2017 -53.57%
Sep 30, 2017 42.05%
Jun 30, 2017 35.86%
Mar 31, 2017 -17.58%
Dec 31, 2016 -49.99%
Sep 30, 2016 48.24%
Jun 30, 2016 25.59%
Mar 31, 2016 -0.29%
Dec 31, 2015 -15.94%
Sep 30, 2015 -13.14%
Jun 30, 2015 -6.19%
Mar 31, 2015 10.91%
Dec 31, 2014 48.71%
Sep 30, 2014 7.24%
Jun 30, 2014 -14.37%
Mar 31, 2014 14.85%
Dec 31, 2013 49.70%
Sep 30, 2013 -20.72%
Jun 30, 2013 8.80%